FTC Warns Of Harm In Generic Parkinson's Drug Antitrust Suit
The Federal Trade Commission told a Delaware federal court that patients could be significantly harmed by the types of distribution restrictions and other activity that Sage Chemical Inc. accuses its rivals...To view the full article, register now.
Already a subscriber? Click here to view full article